Scynexis Inc SEC filings SCYX

Scynexis Inc has 744 filings in SEC EDGAR's recent list, going back to Jul 10, 2002. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.

Scynexis Inc SEC filings
Form Description Filed Period
S-3 Shelf registration Nov 5, 2026 —
S-8 Employee stock plan registration Aug 10, 2026 —
424B3 Prospectus May 8, 2026 —
S-3 Shelf registration May 1, 2026 —
424B5 Prospectus supplement Nov 6, 2024 —
S-8 Employee stock plan registration Jun 20, 2024 —
S-8 Employee stock plan registration Mar 28, 2024 —
424B5 Prospectus supplement Nov 28, 2023 —
424B5 Prospectus supplement Nov 28, 2023 —
S-3 Shelf registration Nov 13, 2023 —
S-3 Shelf registration Nov 13, 2023 —
S-8 Employee stock plan registration Jul 18, 2023 —
S-8 Employee stock plan registration Mar 31, 2023 —
S-8 Employee stock plan registration Nov 10, 2022 —
424B5 Prospectus supplement Apr 22, 2022 —
FWP Free writing prospectus Apr 22, 2022 —
424B5 Prospectus supplement Apr 21, 2022 —
S-8 Employee stock plan registration Mar 30, 2022 —
424B3 Prospectus Sep 17, 2021 —
424B3 Prospectus Sep 17, 2021 —
S-3 Shelf registration Sep 3, 2021 —
424B5 Prospectus supplement May 17, 2021 —
S-8 Employee stock plan registration May 10, 2021 —
S-8 Employee stock plan registration Mar 29, 2021 —
S-3 Shelf registration Dec 31, 2020 —
424B5 Prospectus supplement Dec 17, 2020 —
424B5 Prospectus supplement Dec 16, 2020 —
424B5 Prospectus supplement Oct 2, 2020 —
424B5 Prospectus supplement Oct 2, 2020 —
S-3 Shelf registration Sep 11, 2020 —
424B3 Prospectus May 11, 2020 —
S-3 Shelf registration May 1, 2020 —
424B5 Prospectus supplement Apr 13, 2020 —
S-8 Employee stock plan registration Mar 11, 2020 —
424B5 Prospectus supplement Dec 11, 2019 —
424B5 Prospectus supplement Dec 9, 2019 —
S-8 Employee stock plan registration Aug 7, 2019 —
424B3 Prospectus Mar 29, 2019 —
S-3 Shelf registration Mar 22, 2019 —
S-8 Employee stock plan registration Mar 14, 2019 —
424B3 Prospectus Sep 14, 2018 —
424B5 Prospectus supplement Sep 14, 2018 —
S-3 Shelf registration Aug 31, 2018 —
S-8 Employee stock plan registration Mar 13, 2018 —
424B5 Prospectus supplement Mar 7, 2018 —
424B5 Prospectus supplement Mar 5, 2018 —
S-8 Employee stock plan registration Mar 13, 2017 —
424B5 Prospectus supplement Jun 22, 2016 —
424B5 Prospectus supplement Jun 20, 2016 —
424B5 Prospectus supplement Apr 11, 2016 —
S-8 Employee stock plan registration Mar 7, 2016 —
424B3 Prospectus Nov 17, 2015 —
424B3 Prospectus Nov 17, 2015 —
S-3/A Amendment no. 1 to form s-3 Nov 12, 2015 —
S-3 Shelf registration Oct 30, 2015 —
S-8 Employee stock plan registration Jun 5, 2015 —
S-8 Employee stock plan registration Jun 5, 2015 —
424B4 Prospectus Apr 23, 2015 —
S-1MEF Filing Apr 22, 2015 —
S-1/A Amended registration statement Apr 20, 2015 —
S-1 Registration statement Apr 9, 2015 —
S-8 Employee stock plan registration Mar 17, 2015 —
S-8 Employee stock plan registration Dec 18, 2014 —
S-8 Employee stock plan registration May 16, 2014 —
424B4 Prospectus May 2, 2014 —
S-1/A Amended registration statement Apr 30, 2014 —
FWP Free writing prospectus Apr 2, 2014 —
S-1/A Amended registration statement Apr 2, 2014 —
S-1/A Amended registration statement Mar 19, 2014 —
S-1 Registration statement Feb 27, 2014 —

Showing 70 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SCYX (Nasdaq)
Fiscal year ends
December 31
Headquarters
Jersey City, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1178253

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.